Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Newly diagnosed multiple sclerosis in state of Qatar.
Clinical assessment of noninvasive intracranial pressure absolute value measurement method.
Response to disease modifying therapies in African Americans with multiple sclerosis.
FDA approves injectable drug to treat opioid-dependent patients
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Endogeneous Remyelination: Findings in Human Studies.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)
The role of complementary and alternative medicine in therapy of multiple sclerosis.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Axonal damage in acute multiple sclerosis lesions.
Granzyme B-Induced Neurotoxicity Is Mediated via Activation of PAR-1 Receptor and Kv1.3 Channel.
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
No MRI evidence of cortical lesions in neuromyelitis optica.
Pages
« first
‹ previous
…
152
153
154
155
156
157
158
159
160
…
next ›
last »